Arete Wealth Advisors »

Intra Cellular Therapies shares owned by Arete Wealth Advisors

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Arete Wealth Advisors from 13F filings

Historical chart of Arete Wealth Advisors investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Arete Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Arete Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.0M 24k 83.54
2024-09-30 $1.8M 25k 73.16
2024-03-31 $1.8M 26k 69.20
2023-12-31 $1.8M 26k 71.62
2023-09-30 $1.3M 26k 52.09

More positions owned by Arete Wealth Advisors

Berkshire Hathaway Inc Del Cl A (BRK.A)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Walt Disney Company (DIS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Microsoft Corporation (MSFT)
Vaneck Etf Trust Ig Floating Rate (FLTR)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Arete Wealth Advisors

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Norges Bank Investment Management
Invesco
venBio Select Advisor
Bellevue Group
State Street Corporation
Franklin Resources
Geode Capital Management
ClearBridge Advisors
Pictet Asset Management Holding SA
Deep Track Capital

View all funds holding Intra Cellular Therapies